Somatic Genomic Testing for Metastatic or Advanced Cancer
American Society of Clinical OncologyPublished: February 17, 2022
- Key Points
- Tables
- Select Definitions of Commonly Used Terms in Precision Oncology
- Selected Genetic Alterations Linked to FDA Approvals as of June 2021
- Select Definitions of Commonly Used Terms in Precision Oncology
- Multigene Panel-Based Genomic Sequencing with Disease-Specific Approved Markers
- Assessment of dMMR and/or MSI-H Status, and TMB
- Testing for Gene Fusions and Exon Skipping Variants
- Diseases with No Approved Disease-Specific Markers
- Elements to Consider While Reviewing Genomic Testing Results
- Additional Topics
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.